Millennium Management’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $542K | Buy |
+338,571
| New | +$542K | ﹤0.01% | 3327 |
|
|
2024
Q2 | – | Sell |
-27,744
| Closed | -$331K | – | 4340 |
|
|
2024
Q1 | $331K | Buy |
27,744
+13,965
| +101% | +$167K | ﹤0.01% | 3459 |
|
|
2023
Q4 | $109K | Buy |
+13,779
| New | +$109K | ﹤0.01% | 3684 |
|
|
2023
Q3 | – | Sell |
-7,187
| Closed | -$250K | – | 4459 |
|
|
2023
Q2 | $250K | Sell |
7,187
-18,587
| -72% | -$647K | ﹤0.01% | 3618 |
|
|
2023
Q1 | $562K | Buy |
25,774
+17,064
| +196% | +$372K | ﹤0.01% | 3371 |
|
|
2022
Q4 | $188K | Buy |
8,710
+2,068
| +31% | +$44.6K | ﹤0.01% | 4121 |
|
|
2022
Q3 | $162K | Sell |
6,642
-7,883
| -54% | -$192K | ﹤0.01% | 4537 |
|
|
2022
Q2 | $296K | Sell |
14,525
-3,347
| -19% | -$68.2K | ﹤0.01% | 4251 |
|
|
2022
Q1 | $636K | Sell |
17,872
-7,331
| -29% | -$261K | ﹤0.01% | 3902 |
|
|
2021
Q4 | $686K | Sell |
25,203
-22,810
| -48% | -$621K | ﹤0.01% | 3772 |
|
|
2021
Q3 | $2.08M | Buy |
+48,013
| New | +$2.08M | ﹤0.01% | 2986 |
|
|
2021
Q2 | – | Sell |
-10,001
| Closed | -$450K | – | 5259 |
|
|
2021
Q1 | $450K | Buy |
10,001
+971
| +11% | +$43.7K | ﹤0.01% | 3717 |
|
|
2020
Q4 | $235K | Buy |
+9,030
| New | +$235K | ﹤0.01% | 3649 |
|
|
2017
Q3 | – | Sell |
-196
| Closed | -$31K | – | 3441 |
|
|
2017
Q2 | $31K | Sell |
196
-102
| -34% | -$16.1K | ﹤0.01% | 3136 |
|
|
2017
Q1 | $128K | Sell |
298
-70
| -19% | -$30.1K | ﹤0.01% | 3065 |
|
|
2016
Q4 | $177K | Sell |
368
-160
| -30% | -$77K | ﹤0.01% | 2896 |
|
|
2016
Q3 | $359K | Sell |
528
-23
| -4% | -$15.6K | ﹤0.01% | 2513 |
|
|
2016
Q2 | $300K | Buy |
+551
| New | +$300K | ﹤0.01% | 2493 |
|